Utility of the prostate health index density for detecting clinically significant prostate cancer in patients with negative magnetic resonance imaging findings
Prostate International · 2025-12 · 13 (4) · 271-275
DOI: 10.1016/j.prnil.2025.08.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prostate International, 2025-12. Verfasst von Kazuhiko Oshinomi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Showa Medical University School of Medicine, Tokyo, Japan. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Multiparametric magnetic resonance imaging (MRI) is widely used in prostate cancer diagnosis; however, a significant proportion of clinically important cancers can be missed in patients with negative MRI findings. Although attempts have been made to analyze prostate-specific antigen (PSA)-related parameters to improve the specificity of PSA testing, no evidence-based cutoff values have been established. This study aimed to evaluate the diagnostic performance of the prostate health index (PHI) and PHI density (PHID) in detecting clinically significant prostate cancer (csPCa) in the MRI-negative population.
Methods
A retrospective analysis was conducted on 339 MRI-negative patients with PSA levels of 3-15 ng/mL who underwent PHI testing and MRI between September 2022 and July 2024. MRI-negative patients were defined as those with Prostate Imaging Reporting and Data System (PI-RADS) category 1 or 2 lesions. Biopsies were performed in 181 patients. The diagnostic accuracies of PSA, % free PSA, PHI, PSA density, and PHID were assessed using the receiver operating characteristic curves.
Results
Among the 47 patients with PI-RADS 1 or 2 who underwent biopsy, 24 (51.1%) had prostate cancer, of whom 16 (66.7%) had csPCa. The PHID showed the highest diagnostic performance (area under the curve [AUC] = 0.8832 for any cancer; AUC = 0.7843 for csPCa). Two patients with a PHI
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Showa Medical University School of Medicine, Tokyo, Japan.
Zitieren
APA
Oshinomi, K., Kikuchi, S., Kishi, H., Hayashi, A., Okada, S., Kurokawa, M., Mugita, T., Tsunokawa, Y., Inoue, T., Yamagishi, M., Nakagami, Y., Nagata, M., & Fukagai, T. (2025). Utility of the prostate health index density for detecting clinically significant prostate cancer in patients with negative magnetic resonance imaging findings. Prostate International, 13(4), 271-275. https://doi.org/10.1016/j.prnil.2025.08.004
Vancouver
Oshinomi K, Kikuchi S, Kishi H, Hayashi A, Okada S, Kurokawa M, et al. Utility of the prostate health index density for detecting clinically significant prostate cancer in patients with negative magnetic resonance imaging findings. Prostate International. 2025;13(4):271-275. doi:10.1016/j.prnil.2025.08.004
BibTeX
@article{Oshinomi2025,
author = {Oshinomi, Kazuhiko and Kikuchi, Shota and Kishi, Hirotaka and Hayashi, Anju and Okada, Sho and Kurokawa, Masahiro and Mugita, Toshiki and Tsunokawa, Yoshiki and Inoue, Tatsuki and Yamagishi, Motoki and Nakagami, Yoshihiro and Nagata, Masakazu and Fukagai, Takashi},
title = {Utility of the prostate health index density for detecting clinically significant prostate cancer in patients with negative magnetic resonance imaging findings},
journal = {Prostate International},
year = {2025},
volume = {13},
number = {4},
pages = {271--275},
doi = {10.1016/j.prnil.2025.08.004}
}
EUVIMED